Simon Barton

NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom.

NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom.

NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom.

NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom.

NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom.